Pilot and seed funding for research are keys to bringing new investigators into the field as well as assisting established scientists in changing the direction of their research or to bring their experience into other arenas. The Layton Center is pleased that it can offer several pilot grant programs for new investigators or more experienced investigators who have novel ideas that may advance Alzheimer's research.
Number of project to be funded: 2
Letter of intent: Friday, October 21, 2016 by 5:00 pm
Full application (invited): Friday, November 18, 2016 by 5:00 pm
Goal: The pilot project program of the NIH-funded Oregon Alzheimer Disease Center (OADC) promotes basic and clinical biomedical, translational, epidemiological, caregiving, educational and behavioral research on Alzheimer disease (AD), other dementias, and normal brain aging. The funding provides modest support to allow an investigator to develop preliminary data sufficient to provide the basis for an application for independent research support.
Investigators: Applicants may be either postdoctoral or junior faculty investigators with an interest in research in AD or more senior investigators who have experience in areas other than AD research, and who want to work in the AD research field or who want to try a new hypothesis, method, or approach. OADC resources: Although not required, investigators are encouraged to utilize OADC resources.
Investigators may have access (with IRB approval) to patients and control volunteers with clinical, genetic and neuropathological information; specimens such as DNA, frozen and fixed brain tissue, CSF, and cell lines. Standardized clinical and neuropathological research data collected from all NIH ADCs is available from the NIH-funded National Alzheimer’s Coordinating Center (http://www.alz.washington.edu). Interested investigators are encouraged to consult with OADC faculty.
Letters of Intent (addressed to OADC Executive Committee) should briefly describe the applicant’s research program, career plans, experience in dementia research, as well as briefly summarize purpose and aims of the proposed project (include title) in relation to other current research and to future AD research. Include NIH biosketch for principal investigator(s). Letters should be no more than 1,200 words (Arial 11pt font, 0.5 inch margins), biosketch should follow NIH format and page limit. Grants office review required only for non-OHSU investigators. Submit as one pdf to email@example.com.
For further information, contact Tracy Zitzelberger at 503 494-7198 or firstname.lastname@example.org.
These funds have been made available by Oregonians through the Oregon Income Tax Charitable Checkoff Program.
Grants are awarded annually to clinical, basic, or social scientists for support of research that will advance the understanding, treatment or prevention of Alzheimer's disease. Appropriate fields include the neurosciences, genetics, nursing, social work, epidemiology, sociology, psychology, psychiatry, public health, economics, counseling, delivery of health care services, and others relevant to Alzheimer's research or practice.